Yawning response assessment measures neurophysiological state indicating alertness and arousal level. Excessive yawning indicates sedation or narcolepsy. Absent yawning suggests alertness. Frequency tracking quantitates changes. Objective measurement complements subjective assessment.
Clinical monitoring detects sedation emergence. Dose reduction addresses excessive yawning. Regulatory submissions address sedation risks. Patient counselling emphasises alertness importance. Post-approval surveillance identifies sedation patterns.
General Biopharmaceutical Concepts
Yawning Response Assessment
Yawning response assessment evaluates yawning frequency or intensity as a potential indicator of neurological, pharmacological or physiological effects.
Continue Exploring
Browse over 900 biopharmaceutical terms across biologics, ADCs, cell & gene therapy, CMC, clinical development and manufacturing.
Browse Glossary →